Industry: Service & Software
Published Date: 2025-02-20
Pages: 72 Pages
Report ld: 4018828
Request Sample
Customized Report
The global market for Phenotypic Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Phenotypic Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenotypic Drug Discovery.
The Phenotypic Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Phenotypic Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phenotypic Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phenotypic Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Platform
1.2.3 Service
1.3 Market by Application
1.3.1 Global Phenotypic Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Viral Infection
1.3.4 Genetic Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phenotypic Drug Discovery Market Perspective (2020-2031)
2.2 Global Phenotypic Drug Discovery Growth Trends by Region
2.2.1 Global Phenotypic Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Phenotypic Drug Discovery Historic Market Size by Region (2020-2025)
2.2.3 Phenotypic Drug Discovery Forecasted Market Size by Region (2026-2031)
2.3 Phenotypic Drug Discovery Market Dynamics
2.3.1 Phenotypic Drug Discovery Industry Trends
2.3.2 Phenotypic Drug Discovery Market Drivers
2.3.3 Phenotypic Drug Discovery Market Challenges
2.3.4 Phenotypic Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phenotypic Drug Discovery Players by Revenue
3.1.1 Global Top Phenotypic Drug Discovery Players by Revenue (2020-2025)
3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2020-2025)
3.2 Global Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Phenotypic Drug Discovery Revenue
3.4 Global Phenotypic Drug Discovery Market Concentration Ratio
3.4.1 Global Phenotypic Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phenotypic Drug Discovery Revenue in 2024
3.5 Global Key Players of Phenotypic Drug Discovery Head office and Area Served
3.6 Global Key Players of Phenotypic Drug Discovery, Product and Application
3.7 Global Key Players of Phenotypic Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Phenotypic Drug Discovery Breakdown Data by Type
4.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2020-2025)
4.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2026-2031)
5 Phenotypic Drug Discovery Breakdown Data by Application
5.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2020-2025)
5.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Phenotypic Drug Discovery Market Size (2020-2031)
6.2 North America Phenotypic Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Phenotypic Drug Discovery Market Size by Country (2020-2025)
6.4 North America Phenotypic Drug Discovery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phenotypic Drug Discovery Market Size (2020-2031)
7.2 Europe Phenotypic Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Phenotypic Drug Discovery Market Size by Country (2020-2025)
7.4 Europe Phenotypic Drug Discovery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phenotypic Drug Discovery Market Size (2020-2031)
8.2 Asia-Pacific Phenotypic Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2020-2025)
8.4 Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Phenotypic Drug Discovery Market Size (2020-2031)
9.2 Latin America Phenotypic Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Phenotypic Drug Discovery Market Size by Country (2020-2025)
9.4 Latin America Phenotypic Drug Discovery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phenotypic Drug Discovery Market Size (2020-2031)
10.2 Middle East & Africa Phenotypic Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2020-2025)
10.4 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Details
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery Phenotypic Drug Discovery Introduction
11.1.4 Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2020-2025)
11.1.5 Eurofins Discovery Recent Development
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery Company Details
11.2.2 Sygnature Discovery Business Overview
11.2.3 Sygnature Discovery Phenotypic Drug Discovery Introduction
11.2.4 Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2020-2025)
11.2.5 Sygnature Discovery Recent Development
11.3 PsychoGenics
11.3.1 PsychoGenics Company Details
11.3.2 PsychoGenics Business Overview
11.3.3 PsychoGenics Phenotypic Drug Discovery Introduction
11.3.4 PsychoGenics Revenue in Phenotypic Drug Discovery Business (2020-2025)
11.3.5 PsychoGenics Recent Development
11.4 siTOOLs Biotech
11.4.1 siTOOLs Biotech Company Details
11.4.2 siTOOLs Biotech Business Overview
11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Introduction
11.4.4 siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2020-2025)
11.4.5 siTOOLs Biotech Recent Development
11.5 PhoreMost
11.5.1 PhoreMost Company Details
11.5.2 PhoreMost Business Overview
11.5.3 PhoreMost Phenotypic Drug Discovery Introduction
11.5.4 PhoreMost Revenue in Phenotypic Drug Discovery Business (2020-2025)
11.5.5 PhoreMost Recent Development
11.6 Charles River
11.6.1 Charles River Company Details
11.6.2 Charles River Business Overview
11.6.3 Charles River Phenotypic Drug Discovery Introduction
11.6.4 Charles River Revenue in Phenotypic Drug Discovery Business (2020-2025)
11.6.5 Charles River Recent Development
11.7 MaxWell
11.7.1 MaxWell Company Details
11.7.2 MaxWell Business Overview
11.7.3 MaxWell Phenotypic Drug Discovery Introduction
11.7.4 MaxWell Revenue in Phenotypic Drug Discovery Business (2020-2025)
11.7.5 MaxWell Recent Development
11.8 Arctoris
11.8.1 Arctoris Company Details
11.8.2 Arctoris Business Overview
11.8.3 Arctoris Phenotypic Drug Discovery Introduction
11.8.4 Arctoris Revenue in Phenotypic Drug Discovery Business (2020-2025)
11.8.5 Arctoris Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 105
USD 3950.00
(Single User License)
The global Phenotypic Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 110
USD 2900.00
(Single User License)
The global Phenotypic Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 125
USD 4900.00
(Single User License)
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 90
USD 3950.00
(Single User License)
Market Analysis and Insights: Global Phenotypic Drug Discovery Market
Published Date: 2024-04-11
Pages: 99
USD 4900.00
(Single User License)
The global Phenotypic Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 70
USD 2900.00
(Single User License)
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-06
Pages: 97
USD 3950.00
(Single User License)
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 105
The global Phenotypic Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 110
The global Phenotypic Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 125
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 90
Market Analysis and Insights: Global Phenotypic Drug Discovery Market
Published: 2024-04-11
Pages: 99
The global Phenotypic Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 70
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-06
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now